Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

SORORIN is an evolutionary conserved antagonist of WAPL

SORORIN is an evolutionary conserved antagonist of WAPL

FromPaperPlayer biorxiv cell biology


SORORIN is an evolutionary conserved antagonist of WAPL

FromPaperPlayer biorxiv cell biology

ratings:
Length:
20 minutes
Released:
Oct 24, 2022
Format:
Podcast episode

Description

Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2022.10.24.513534v1?rss=1

Authors: Prusen Mota, I., Galova, M., Schleiffer, A., Nguyentan, T.-t., Kovacikova, I., Nishiyama, T., Gregan, J., Peters, J.-M., Schlogelhofer, P.

Abstract:
Cohesin mediates sister chromatid cohesion to enable chromosome segregation and DNA damage repair. To perform these functions, cohesin needs to be protected from WAPL, which otherwise releases cohesin from DNA. It has been proposed that cohesin is protected from WAPL by SORORIN. However, in vivo evidence for this antagonism is missing and SORORIN is only known to exist in vertebrates and insects. It is therefore unknown how important and widespread SORORINs functions are. Here we report the identification of SORORIN orthologs in Schizosaccharomyces pombe (Sor1) and Arabidopsis thaliana (AtSORORIN). sor1 delta mutants display cohesion defects, which are partially alleviated by wpl1 delta. Atsororin mutant plants display dwarfism, tissue specific cohesion defects and chromosome mis-segregation. Furthermore, Atsororin mutant plants are sterile and separate sister chromatids prematurely at anaphase I. The somatic, but not the meiotic deficiencies can be alleviated by loss of WAPL. These results provide in vivo evidence for SORORIN antagonizing WAPL, reveal that SORORIN is present in organisms beyond the animal kingdom and indicate that it has acquired tissue specific functions in plants.

Copy rights belong to original authors. Visit the link for more info

Podcast created by Paper Player, LLC
Released:
Oct 24, 2022
Format:
Podcast episode

Titles in the series (100)

Audio versions of bioRxiv and medRxiv paper abstracts